Stephen Kennedy Smith
Fondateur chez Pear Therapeutics (US), Inc.
Profil
Stephen Kennedy Smith is the founder of Pear Therapeutics (US), Inc., where he holds the title of Executive Vice President-Corporate Development.
Pear Therapeutics (US), Inc. was founded in 2013.
He also served as a Director at Med-Design Corp.
In terms of education, Mr. Smith holds graduate degrees from The Trustees of Columbia University in The City of New York, Harvard University, and Harvard Graduate School of Education.
Postes actifs de Stephen Kennedy Smith
| Sociétés | Poste | Début |
|---|---|---|
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Fondateur | 12/06/2014 |
Anciens postes connus de Stephen Kennedy Smith
| Sociétés | Poste | Fin |
|---|---|---|
| Med-Design Corp. | Directeur/Membre du Conseil | 07/06/2006 |
Formation de Stephen Kennedy Smith
| Harvard University | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Harvard Graduate School of Education | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Med-Design Corp. | Health Technology |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Technology Services |
